IP Library Granted Patent US 12,458,423
Granted Patent B2
US 12,458,423 · App. 17/489,213 · Granted Nov 4, 2025

Multi-modality ablation catheter having a shape memory stylet

Inventors: Kevin D. Rupp (Irvine, CA); Alexei V. Babkin (Dana Point, CA); Shirzad Shahriari (Laguna Hills, CA); Hou Man Chong (La Palma, CA); Pedram Nourian (Tustin, CA); Faysal S. Ahmed (Irvine, CA)
Assignee: Adagio Medical, Inc.
A61B18/02A61B18/0218A61B18/1206A61B18/1477A61B18/1492A61B2017/00867A61B2018/00011A61B2018/00077A61B2018/00166A61B2018/00178A61B2018/00351A61B2018/00577A61B2018/00613A61B2018/00648A61B2018/00714A61B2018/00761A61B2018/00767A61B2018/00791A61B2018/00839A61B2018/00994A61B2018/0212A61B2018/0262A61B2018/1253A61B2018/126A61B2018/1467A61B2218/002A61B2560/0266A61M25/0102A61M25/0158
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,458,423
App. No.
17/489,213
Filed
Sep 29, 2021
Granted
Nov 4, 2025
Kind
B2
Art Unit
3794
USPC
606/21
Abstract

A multimodality or hybrid ablation system includes an ablation apparatus for creating a lesion in target tissue. The ablation apparatus has an ablation shaft including a handle, a first portion, an ablation portion, distal tip, at least one ablation energy delivery lumen, at least one ablation energy return lumen, and a stylet lumen that extends substantially along a length of the ablation shaft from the handle to at least the ablation portion. The ablation apparatus also includes a stylet that is capable of being inserted into the stylet lumen where the stylet is made of a shape-memory material. A plurality of electrodes are arranged on the ablation portion for measuring or verifying tissue contact with the tissue and applying a pulsed electric field. Optionally, the pulsed electric field may be applied after, contemporaneously, or for only a portion that the cryo-modality is applied to the target tissue.

Claims (20)

1 . A multimodality ablation system for creating a lesion in target tissue, the system comprising:

a catheter, said catheter comprising:

a linear non-expanding and non-inflatable freezing portion;

at least one cryogen delivery lumen extending along the freezing portion;

at least one cryogen return lumen extending along the freezing portion;

an endcap extending from the freezing portion and comprising a fixed shape defining an internal cavity in which a cryogen is exchanged between the at least one cryogen delivery lumen and the at least one cryogen return lumen; and

a plurality of electrodes on an exterior surface of the freezing portion;

a cryogen controller, the cryogen controller operable to, for a first duration, circulate a cryogen through the freezing portion using the at least one cryogen delivery and return tubes such that a first volume of target tissue around the freezing portion is frozen, said first volume of target tissue comprising an interior, an ice penetration depth, and a boundary layer; and

a pulsed field ablation generator operably coupled to the plurality of electrodes to, for a second duration, create a pulsed field of electricity and defining an electric field depth to induce cell death in the target tissue at the boundary layer of the first volume of target tissue, and

wherein ablation arising from the pulsed field ablation generator is coordinated with ablation arising from the cryogen controller such that the electric field depth matches, but does not extend beyond, the ice penetration depth.

2 . The system of claim 1 , wherein the pulsed field ablation generator is operable to commence the second duration to overlap with the first duration.

3 . The system of claim 2 , wherein the pulsed field ablation generator is operable to commence the second duration after first duration has commenced.

4 . The system of claim 3 , wherein the pulsed field ablation generator is programmed operable to commence the second duration after 80% of the first duration has elapsed.

5 . The system of claim 4 , wherein the first duration ranges from 10 to 40 seconds.

6 . The system of claim 1 , wherein the first volume is characterized by a penetration depth from the freezing portion that the tissue freezes, and the penetration depth is at least 2 mm.

7 . The system of claim 1 , wherein the catheter further comprises a stylet lumen that extends substantially along a length of the ablation shaft from the handle to at least the freezing portion; and a stylet capable of being inserted into the stylet lumen, the stylet comprising a pre-set shape.

8 . The system of claim 7 , wherein the pre-set shape of the stylet is an open loop, thereby, when the stylet is fully inserted in the catheter, configures the catheter into a linear open loop shape.

9 . The system of claim 1 , further comprising a tissue contact module operable to measure tissue contact information based on information detected by the plurality of electrodes.

10 . The system of claim 1 , wherein a ratio of the penetration depth to the depth of the electric field is about 1.

11 . The system of claim 1 , wherein the electric field is characterized at the penetration depth by at least 400 V/cm.

Assignments (2)
SECURITY INTEREST Recorded Aug 6, 2024
From: ADAGIO MEDICAL HOLDINGS, INC.
To: ALLEGRO MANAGEMENT LLC
Reel/Frame 068337/0332 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 10, 2022
From: BABKIN, ALEXEI V; NOURIAN, PEDRAM; SHAHRIARI, SHIRZAD; AHMED, FAYSAL; CHONG, HOU MAN; RUPP, KEVIN D
To: ADAGIO MEDICAL, INC.
Reel/Frame 058602/0946 →
Continuity (4)
Continuation In Part PCTUS2021024046 · Mar 25, 2021
Provisional Application 63137810 · Jan 15, 2021
Provisional Application 63000400 · Mar 26, 2020
Related Publication 20220071681A1 · Mar 10, 2022
References Cited (77)
US 6161543A · Cox et al. · 2000 [cited by applicant]
US 6190382B1 · Ormsby et al. · 2001 [cited by applicant]
US 6941953B2 · Feld et al. · 2005 [cited by applicant]
US 7083612B2 · Littrup et al. · 2006 [cited by applicant]
US 7273479B2 · Littrup et al. · 2007 [cited by applicant]
US 7410484B2 · Littrup et al. · 2008 [cited by applicant]
US 7507233B2 · Littrup et al. · 2009 [cited by applicant]
US 7921657B2 · Littrup et al. · 2011 [cited by applicant]
US 8177780B2 · Cox et al. · 2012 [cited by applicant]
US 8221411B2 · Francischelli et al. · 2012 [cited by applicant]
US 8387402B2 · Littrup et al. · 2013 [cited by applicant]
US 8591503B2 · Littrup et al. · 2013 [cited by applicant]
US 8740891B2 · Babkin et al. · 2014 [cited by applicant]
US 8740892B2 · Babkin et al. · 2014 [cited by applicant]
US 9113911B2 · Sherman · 2015 [cited by applicant]
US 9408656B2 · Littrup et al. · 2016 [cited by applicant]
US 10271893B2 · Stewart et al. · 2019 [cited by applicant]
US 10543032B2 · Babkin · 2020 [cited by applicant]
US 10575156B2 · Shedletsky et al. · 2020 [cited by applicant]
US 10617459B2 · Yu et al. · 2020 [cited by applicant]
US 10952676B2 · Babkin et al. · 2021 [cited by applicant]
US 20030195605A1 · Kovalcheck et al. · 2003 [cited by applicant]
US 20110160514A1 · Long et al. · 2011 [cited by applicant]
US 20120065631A1 · Arless · 2012 [cited by examiner]
US 20120209273A1 · Zaretzka · 2012 [cited by examiner]
US 20130030425A1 · Stewart · 2013 [cited by examiner]
US 20130030472A1 · Stewart et al. · 2013 [cited by applicant]
US 20130110098A1 · Lalonde · 2013 [cited by applicant]
US 20140066913A1 · Sherman · 2014 [cited by examiner]
US 20140088578A1 · Rubinsky et al. · 2014 [cited by applicant]
US 20150018809A1 · Mihalik · 2015 [cited by applicant]
US 20170035499A1 · Stewart et al. · 2017 [cited by applicant]
US 20170119465A1 · Long et al. · 2017 [cited by applicant]
US 20180028252A1 · Lalonde · 2018 [cited by applicant]
US 20180085160A1 · Viswanathan et al. · 2018 [cited by applicant]
US 20180325577A1 · Martin et al. · 2018 [cited by applicant]
US 20190038334A1 · Schwartz · 2019 [cited by applicant]
US 20190076179A1 · Babkin et al. · 2019 [cited by applicant]
US 20190125422A1 · Babkin et al. · 2019 [cited by applicant]
US 20190223948A1 · Stewart et al. · 2019 [cited by applicant]
US 20190254735A1 · Stewart et al. · 2019 [cited by applicant]
US 20190262056A1 · Yang et al. · 2019 [cited by applicant]
US 20190365451A1 · Jung, Jr. · 2019 [cited by applicant]
US 20210059737A1 · Babkin et al. · 2021 [cited by applicant]
US 20210259765A1 · Narayan · 2021 [cited by applicant]
US 20210307824A1 · Asirvatham et al. · 2021 [cited by applicant]
CN 107693114A · 2018 [cited by applicant]
EP 2892455B1 · 2015 [cited by applicant]
WO 2012057915A1 · 2012 [cited by applicant]
WO 2013013098A1 · 2013 [cited by applicant]
WO 2013013099A1 · 2013 [cited by applicant]
WO 2013163469A1 · 2013 [cited by applicant]
WO 2013181660A1 · 2013 [cited by applicant]
WO 2015160574A1 · 2015 [cited by applicant]
WO 2017048965A1 · 2017 [cited by applicant]
WO WO2019050894A1 · 2019 [cited by examiner]
WO 2019164650A1 · 2019 [cited by applicant]
WO 2020028282A1 · 2020 [cited by applicant]
WO 2021195311A1 · 2021 [cited by applicant]
Daniels CS, Rubinsky B., Cryosurgery with pulsed electric fields. PLoS One. vol. 6 (Nov. 7, 2011):e26219. doi: 10.1371/journal.pone.0026219. Epub Nov. 7, 2011. PMID: 22087224; Pmcid: PMC3210118. [cited by applicant]
International Search Report and Written Opinion of the ISA dated Aug. 5, 2021 for PCT/US2021/024046. [cited by applicant]
Barkagan et al. A novel multielectrode catheter for high-density ventricular mapping: electrogram characterization and utility for scar mapping. Online Jan. 2020. Europace. Mar. 1, 2020;22(3):440-449. doi: 10.1093/europ… [cited by applicant]
Bunch TJ, Cutler MJ. Is pulmonary vein isolation still the cornerstone in atrial fibrillation ablation? J Thorac Dis. Feb. 2015;7(2):132-41. [cited by applicant]
Callans DJ, Gerstenfeld EP, Dixit S, et al. Efficacy of repeat pulmonary vein isolation procedures in patients with recurrent atrial fibrillation. J Cardiovasc Electrophysiol 2004; 15:1050-5. [cited by applicant]
Golberg A, Rubinsky B, A statistical model for multidimensional irreversible electroporation cell death in tissue. Biomed Eng Online. Feb. 26, 2010;9:13. doi: 10.1186/1475-925X-9-13. Pmid: 20187951; PMCID: PMC2839970. [cited by applicant]
International Search Report and Written Opinion of the ISA dated Dec. 16, 2022 for PCT/US2022/076874. [cited by applicant]
Kim et al. Linear ablation in addition to circumferential pulmonary vein isolation (Dallas lesion set) does not improve clinical outcome in patients with paroxysmal atrial fibrillation: a prospective randomized study. E… [cited by applicant]
Kowalski M, Grimes MM, Perez FJ, et al. Histopathologic characterization of chronic radiofrequency ablation lesions for pulmonary vein isolation. J Am Coll Cardiol 2012;59:930-8. [cited by applicant]
McGann CJ, Kholmovski EG, Oakes RS, et al. New magnetic resonance imaging-based method for defining the extent of left atrial wall injury after the ablation of atrial fibrillation. J Am Coll Cardiol 2008;52:1263-71. [cited by applicant]
Ouyang F, Tilz R, Chun J, et al. Long-term results of catheter ablation in paroxysmal atrial fibrillation: lessons from a 5-year follow-up. Circulation 2010;122:2368-77. [cited by applicant]
Ranjan R, Kato R, Zviman MM, et al. Gaps in the ablation line as a potential cause of recovery from electrical isolation and their visualization using MRI. Circ Arrhythm Electrophysiol 2011;4:279-86. [cited by applicant]
Sawhney N, Anousheh R, Chen WC, et al. Five-year outcomes after segmental pulmonary vein isolation for paroxysmal atrial fibrillation. Am J Cardiol 2009;104:366-72. [cited by applicant]
Terricabras M, Piccini JP, Verma A., Ablation of persistent atrial fibrillation: Challenges and solutions. J Cardiovasc Electrophysiol. Jul. 2020;31(7):1809-1821. doi: 10.1111/jce.14311. Epub Dec. 18, 2019. PMID: 318288… [cited by applicant]
Verma A, Kilicaslan F, Pisano E, et al. Response of atrial fibrillation to pulmonary vein antrum isolation is directly related to resumption and delay of pulmonary vein conduction. Circulation 2005;112:627-35. [cited by applicant]
Extended European Search Report of EP21776726.8 dated Feb. 29, 2024. [cited by applicant]
Office Action of the Canadian patent application No. 3,171,761 issued on Oct. 16, 2024. [cited by applicant]
Office Action of the Canadian patent application No. 3,171,761 issued on Nov. 21, 2023. [cited by applicant]
Cited By (1)
US 12,673,186